Page last updated: 2024-09-04

cyc 202 and Abnormalities, Autosome

cyc 202 has been researched along with Abnormalities, Autosome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Galons, H; Hunt, KK; Jabbour, NA; Joseph, B; Keyomarsi, K; Meijer, L; Multani, AS; Nanos-Webb, A; Oumata, N; Wingate, H	1

Other Studies

1 other study(ies) available for cyc 202 and Abnormalities, Autosome

Article	Year
Targeting low molecular weight cyclin E (LMW-E) in breast cancer. Breast cancer research and treatment, 2012, Volume: 132, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromosome Aberrations; Cyclin E; Cyclin-Dependent Kinase 2; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Enzyme Induction; Female; Genomic Instability; Humans; Molecular Weight; Polyploidy; Protein Kinase Inhibitors; Purines; Roscovitine; Time Factors; Transfection	2012

Article

Year

Targeting low molecular weight cyclin E (LMW-E) in breast cancer.

Breast cancer research and treatment, 2012, Volume: 132, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromosome Aberrations; Cyclin E; Cyclin-Dependent Kinase 2; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Enzyme Induction; Female; Genomic Instability; Humans; Molecular Weight; Polyploidy; Protein Kinase Inhibitors; Purines; Roscovitine; Time Factors; Transfection

2012